BioSpace News Archive

Due to limitations necessitated by COVID-19, clinical trials have undergone a transformation. In tandem with telemedicine, decentralized clinical trials (DCTs) are gaining traction and, today, they are at the forefront of nearly every research-related conversation.

The University of Texas MD Anderson Cancer Center and BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced a strategic alliance to advance the development and clinical integration of multiplatform biomarker signatures.

The Company submitted a briefing package to the FDA, Office of Infectious Diseases, Center for Drug Evaluation and Research for cepharanthine and awaits further feedback on its proposed path toward human clinical development.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, announced the launch of Angled Endplate implants for the prodisc® L Lumbar Total Disc Replacement System.

Mitochon Pharmaceuticals today is pleased to announce the receipt of a $500,000 grant in conjunction with the University of Kentucky for “Advancement of Drugs for the Treatment of Repeated Mild Traumatic Brain Injury (mTBI)” through a joint funded program by an Alzheimer’s Disease group, BrightFocus Foundation and a military focused foundation, Medical Technology Enterprise Consortium (MTEC).

Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD).

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced that its Chief Executive Officer Waqaas Al Siddiq is scheduled to present at the virtual Benzinga Healthcare Small Cap Conference on Thursday, September 30, 2021 at 12:15 p.m. ET.

RMJ Holdings, LLC (RMJH), today announced that data on its first drug candidate RMJH-111B, a novel drug candidate for essential hypertension, is being presented in a poster at the American Heart Association’s Hypertension 2021 Scientific Sessions.

Simulated Inanimate Models, Inc (SIM Inc.), a designer and manufacturer of realistic anatomical models for surgical simulation and biomedical education, today announced the appointment of Jeff Sherman as SIM’s Chief Commercial Officer, effective September 27, 2021.

LifeNet Health, the world leader in allograft biologics, has optimized its industry-leading cellular bone matrix for minimally invasive surgery with the launch of ViviGen® MIS Delivery System, a major improvement in precision, efficiency and reliability over traditional bone-graft delivery.